Results 31 to 40 of about 23,057 (164)

Trypanosoma evansi is alike to Trypanosoma brucei brucei in the subcellular localisation of glycolytic enzymes

open access: yesMemorias do Instituto Oswaldo Cruz, 2015
Trypanosoma evansi, which causes surra, is descended from Trypanosoma brucei brucei, which causes nagana. Although both parasites are presumed to be metabolically similar, insufficient knowledge of T. evansi precludes a full comparison.
S Andrea Moreno, Mayerly Nava
doaj   +1 more source

Neurotransmitters in 3-phosphoglycerate dehydrogenase deficiency

open access: yesEuropean Journal of Pediatrics, 2000
Item does not contain ...
Koning, T.J.   +6 more
openaire   +5 more sources

Expanding the clinical spectrum of 3‐phosphoglycerate dehydrogenase deficiency [PDF]

open access: yesJournal of Inherited Metabolic Disease, 2010
Abstract3‐Phosphoglycerate dehydrogenase (3‐PGDH) deficiency is considered to be a rare cause of congenital microcephaly, infantile onset of intractable seizures and severe psychomotor retardation. Here, we report for the first time a very mild form of genetically confirmed 3‐PGDH deficiency in two siblings with juvenile onset of absence seizures and ...
Tabatabaie, L.   +6 more
openaire   +3 more sources

Transient Glycolytic Complexation of Arsenate Enhances Resistance in the Enteropathogen Vibrio cholerae

open access: yesmBio, 2022
The ubiquitous presence of toxic arsenate (AsV) in the environment has raised mechanisms of resistance in all living organisms. Generally, bacterial detoxification of AsV relies on its reduction to arsenite (AsIII) by ArsC, followed by the export of ...
Emilio Bueno   +7 more
doaj   +1 more source

3‐phosphoglycerate dehydrogenase deficiency in a patient with West syndrome [PDF]

open access: yesDevelopmental Medicine & Child Neurology, 2000
3‐phosphoglycerate dehydrogenase deficiency is a severe but treatable disorder of serine synthesis, first described in 1996 (Jaeken et al. 1996a). The patient presented with West syndrome, severe psychomotor delay, failure to thrive, microcephaly, atypical ocular movements, and pyramidal signs.
Pineda M   +8 more
openaire   +4 more sources

3-PGDH Deficiency, Seizures, and Microcephaly

open access: yesPediatric Neurology Briefs, 1998
The beneficial effects of oral L-serine (up to 500 mg/kg/day) and glycine (200 mg/kg/day) in 2 siblings, aged 7 and 5 years, with 3-phosphoglycerate dehydrogenase (3-PGDH) deficiency are reported from University Children’s Hospital, Utrecht, The ...
J Gordon Millichap
doaj   +1 more source

Expressions and roles of key enzymes in serine synthesis pathway in NaAsO2-treated HaCaT cells

open access: yes环境与职业医学, 2022
BackgroundThe key enzymes of serine synthesis pathway (SSP) play an important role in tumor growth, proliferation, and invasion, but their roles in arsenic carcinogenesis are unclear.ObjectiveTo observe the effects of NaAsO2 treatment on the expressions ...
Fengmin LI   +5 more
doaj   +1 more source

The activation of 3‐phosphoglycerate dehydrogenase by L‐methionine [PDF]

open access: yesFEBS Letters, 1970
Feedback inhibition within the metabolic pathways leading to amino acid biosynthesis is well known in a variety of organisms including higher plants [ 1,2] . Most of the information refers to the effects of amino acids on their own biosynthesis but Jensen [3] has recently pointed out that a regulatory superstructure connecting various metabolic ...
openaire   +2 more sources

Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis [PDF]

open access: yesNature Genetics, 2011
Most tumors exhibit increased glucose metabolism to lactate, however, the extent to which glucose-derived metabolic fluxes are used for alternative processes is poorly understood. Using a metabolomics approach with isotope labeling, we found that in some cancer cells a relatively large amount of glycolytic carbon is diverted into serine and glycine ...
Locasale, Jason W.   +25 more
openaire   +4 more sources

Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC

open access: yesNature Communications, 2019
Resistance to the tyrosine kinase inhibitor Sorafenib, which is the standard treatment for advanced hepatocellular carcinoma, is a major clinical challenge.
Lai Wei   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy